Medexus Pharmaceuticals Inc.

TSX:MDP Rapport sur les actions

Capitalisation boursière : CA$59.9m

Medexus Pharmaceuticals Gestion

Gestion contrôle des critères 2/4

Le PDG Medexus Pharmaceuticals est Ken d'Entremont, nommé en Dec2018, a un mandat de 5.92 ans. La rémunération annuelle totale est $ 1.11M, composée du salaire de 46.8% et des bonus 53.2%, y compris les actions et options de la société. détient directement 5.99% des actions de la société, d'une valeur de CA$ 3.59M. La durée moyenne de mandat de l'équipe de direction et du conseil d'administration est respectivement 4.5 ans et 6.1 ans.

Informations clés

Ken d'Entremont

Directeur général

US$1.1m

Rémunération totale

Pourcentage du salaire du PDG46.8%
Durée du mandat du directeur général5.9yrs
Propriété du PDG6.0%
Durée moyenne d'occupation des postes de direction4.5yrs
Durée moyenne du mandat des membres du conseil d'administration6.1yrs

Mises à jour récentes de la gestion

Recent updates

There May Be Reason For Hope In Medexus Pharmaceuticals' (TSE:MDP) Disappointing Earnings

Aug 19
There May Be Reason For Hope In Medexus Pharmaceuticals' (TSE:MDP) Disappointing Earnings

Medexus Pharmaceuticals Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Aug 10
Medexus Pharmaceuticals Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Medexus Pharmaceuticals Inc. (TSE:MDP) Shares Fly 29% But Investors Aren't Buying For Growth

Jul 31
Medexus Pharmaceuticals Inc. (TSE:MDP) Shares Fly 29% But Investors Aren't Buying For Growth

The Market Doesn't Like What It Sees From Medexus Pharmaceuticals Inc.'s (TSE:MDP) Revenues Yet

Jun 15
The Market Doesn't Like What It Sees From Medexus Pharmaceuticals Inc.'s (TSE:MDP) Revenues Yet

Here's Why Medexus Pharmaceuticals (TSE:MDP) Has A Meaningful Debt Burden

Apr 25
Here's Why Medexus Pharmaceuticals (TSE:MDP) Has A Meaningful Debt Burden

Revenues Working Against Medexus Pharmaceuticals Inc.'s (TSE:MDP) Share Price Following 26% Dive

Mar 03
Revenues Working Against Medexus Pharmaceuticals Inc.'s (TSE:MDP) Share Price Following 26% Dive

Medexus Pharmaceuticals Inc.'s (TSE:MDP) Shares Leap 89% Yet They're Still Not Telling The Full Story

Jan 06
Medexus Pharmaceuticals Inc.'s (TSE:MDP) Shares Leap 89% Yet They're Still Not Telling The Full Story

Here's Why Medexus Pharmaceuticals (TSE:MDP) Has Caught The Eye Of Investors

Oct 11
Here's Why Medexus Pharmaceuticals (TSE:MDP) Has Caught The Eye Of Investors

Is Medexus Pharmaceuticals (TSE:MDP) Using Too Much Debt?

Sep 11
Is Medexus Pharmaceuticals (TSE:MDP) Using Too Much Debt?

Medexus Pharmaceuticals (TSE:MDP) Use Of Debt Could Be Considered Risky

Jan 19
Medexus Pharmaceuticals (TSE:MDP) Use Of Debt Could Be Considered Risky

Is Medexus Pharmaceuticals (TSE:MDP) Using Too Much Debt?

Sep 22
Is Medexus Pharmaceuticals (TSE:MDP) Using Too Much Debt?

Is Medexus Pharmaceuticals (TSE:MDP) Weighed On By Its Debt Load?

Dec 16
Is Medexus Pharmaceuticals (TSE:MDP) Weighed On By Its Debt Load?

Medexus Pharmaceuticals Inc. (TSE:MDP) Analysts Just Cut Their EPS Forecasts Substantially

Aug 21
Medexus Pharmaceuticals Inc. (TSE:MDP) Analysts Just Cut Their EPS Forecasts Substantially

Is Medexus Pharmaceuticals (TSE:MDP) Using Too Much Debt?

Aug 04
Is Medexus Pharmaceuticals (TSE:MDP) Using Too Much Debt?

Analyse de la rémunération des PDG

Comment la rémunération de Ken d'Entremont a-t-elle évolué par rapport aux bénéfices de Medexus Pharmaceuticals?
DateRémunération totaleSalaireBénéfices de l'entreprise
Jun 30 2024n/an/a

US$1m

Mar 31 2024US$1mUS$517k

-US$214k

Dec 31 2023n/an/a

US$6m

Sep 30 2023n/an/a

US$5m

Jun 30 2023n/an/a

US$3m

Mar 31 2023US$882kUS$400k

US$1m

Dec 31 2022n/an/a

-US$11m

Sep 30 2022n/an/a

-US$11m

Jun 30 2022n/an/a

US$2m

Mar 31 2022US$592kUS$400k

-US$3m

Dec 31 2021n/an/a

-US$8m

Sep 30 2021n/an/a

-US$20m

Jun 30 2021n/an/a

-US$31m

Mar 31 2021US$688kUS$328k

-US$28m

Dec 31 2020n/an/a

-US$19m

Sep 30 2020n/an/a

-US$9m

Jun 30 2020n/an/a

-US$7m

Mar 31 2020US$385kUS$300k

-US$5m

Dec 31 2019n/an/a

-US$4m

Sep 30 2019n/an/a

-US$3m

Jun 30 2019n/an/a

-US$6m

Mar 31 2019US$2mUS$144k

-US$5m

Rémunération vs marché: La rémunération totale de Ken ($USD 1.11M ) est supérieure à la moyenne des entreprises de taille similaire sur le marché Canadian ($USD 172.63K ).

Rémunération et revenus: La rémunération de Ken a augmenté de plus de 20 % tandis que les bénéfices de l'entreprise ont chuté de plus de 20 % au cours de l'année écoulée.


PDG

Ken d'Entremont

5.9yrs

Titularisation

US$1,106,271

Compensation

Mr. Kenneth d'Entremont, also known as Ken, has been Chief Executive Officer at Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) since December 17,2018 and served as its Chief Operating Officer sinc...


Équipe de direction

NomPositionTitularisationCompensationPropriété
Kenneth d'Entremont
CEO & Director5.9yrsUS$1.11m5.99%
CA$ 3.6m
Richard Labelle
Chief Operating Officerno dataUS$374.12k0.093%
CA$ 55.7k
Ian Wildgoose Brown
General Counsel & Corporate Secretary3yrsUS$446.08k0.084%
CA$ 50.1k
Brendon Buschman
Chief Financial Officerless than a yearpas de donnéespas de données
Tina Byers
Executive of Investor Relationsno datapas de donnéespas de données
Bill Poncy
Senior Vice President of Commercial Operations - United States6.1yrsUS$439.69kpas de données
Brian Peters
Vice President of Sales & Marketing - United Statesno dataUS$281.91kpas de données

4.5yrs

Durée moyenne de l'emploi

Gestion expérimentée: L'équipe de direction de MDP est considérée comme expérimentée (ancienneté moyenne 4.5 ans).


Membres du conseil d'administration

NomPositionTitularisationCompensationPropriété
Kenneth d'Entremont
CEO & Director6.1yrsUS$1.11m5.99%
CA$ 3.6m
Michael Mueller
Independent Chairman10.5yrsUS$94.71k0.39%
CA$ 235.9k
Benoit Gravel
Independent Director7.2yrsUS$83.38k0.26%
CA$ 154.4k
Stephen Nelson
Independent Director6.1yrsUS$73.94k2.25%
CA$ 1.3m
Nancy Phelan
Independent Director1.2yrsUS$39.27k0.045%
CA$ 27.1k
Harmony Garges
Independent Director1.8yrsUS$62.92k0.099%
CA$ 59.3k
Menassie Taddese
Independent Director1.8yrsUS$66.90k0.099%
CA$ 59.3k

6.1yrs

Durée moyenne de l'emploi

55yo

Âge moyen

Conseil d'administration expérimenté: Les membres du conseil d'administration de MDP sont considérés comme expérimentés (ancienneté moyenne 6.1 ans).